Three out of four adults who begin taking a GLP-1 medication stop using it within a year.

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

As GLP‑1 medications become increasingly common for diabetes management and weight loss, questions have emerged about whether they influence the risk of developing kidney stones. Kyle Wood, M.D., MBA, ...

GLP-1 weight-loss drugs alter brain circuits in the amygdala and dopamine system to reduce the motivation to seek out high-calorie foods.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A GLP-1 injection pen, now just a few clicks away, raising questions about convenience, ...

GLP-1-class weight-loss drugs can help users shed dozens of pounds, leading to a more active, energized life. One in eight ...

Share on Pinterest Research shows that GLP-1s may help lower blood pressure levels. Image Credit: Tatiana Maksimova/Getty Images A recent study found that GLP-1 drugs like Ozempic and Wegovy may ...

GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking ...

A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...

Eating the same meals every day may aid in weight loss, according to a study of real-time food tracking data. (Health Psychology) The prevalence of youth-onset type 2 diabetes increased substantially ...

GLP-1 medications such as Ozempic and Wegovy have transformed treatment for Type 2 diabetes and obesity, but new research suggests doctors may need to pay closer attention to bone health, especially ...

GLP‑1 drugs appear to change how much we want to eat, and how strongly food “pulls” on the brain. Newer oral versions may ...